Leerink Swann Downgrades Salix Pharmaceuticals (SLXP) to Market Perform
Leerink Swann downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
